Literature DB >> 2429979

Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities.

M P Nair, E W Lewis, S A Schwartz.   

Abstract

Peripheral blood lymphocytes from 13 patients with established insulin-dependent diabetes mellitus (IDDM) and 2 prediabetic patients were examined for natural killer (NK) and antibody-dependent cellular cytotoxic activities (ADCC), lectin-dependent cellular cytotoxicity (LDCC), interferon- and interleukin-2-induced cytotoxicity, and concanavalin A-induced suppressor-cell activities in comparison with age-matched normal controls. IDDM patients demonstrated normal levels of NK and ADCC activities against K562 and antibody-coated SB target cells, respectively, compared to controls. IDDM patients showed normal levels of LDCC activity. Notable deviations from control values were, however, observed with diabetic lymphocytes in the following systems. Interferon- and interleukin-2-induced NK activities were significantly higher with IDDM lymphocytes than with control cells. IDDM lymphocytes precultured with concanavalin A demonstrated lower NK and ADCC activities than control cells and manifested decreased suppressor effects on the NK activity of normal allogeneic lymphocytes. Lymphocytes from one of two prediabetic patients showed increased NK, ADCC, and LDCC activities in comparison to controls. The increased interferon- and interleukin-2-induced enhancement of NK activity and reduced suppressor activity of lymphocytes from IDDM patients may be involved in the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429979     DOI: 10.1007/bf00915375

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  44 in total

1.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

2.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

3.  Enhancement of human natural killer cells by interferon requires RNA and protein synthesis.

Authors:  G A Bishop; S A Schwartz
Journal:  Clin Immunol Immunopathol       Date:  1982-12

4.  Role of insulin in the intermediary metabolism of the activated thymic-derived lymphocyte.

Authors:  J H Helderman
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

5.  Suppressor T cell function in diabetes mellitus.

Authors:  S D Horowitz; W Borcherding; G J Bargman
Journal:  Lancet       Date:  1977-12-17       Impact factor: 79.321

6.  Autologous mixed lymphocyte reaction in man: XV. Cellular and molecular basis of deficient autologous mixed lymphocyte response in insulin-dependent diabetes mellitus.

Authors:  K G Chandy; A M Charles; A Kershnar; B Buckingham; N Waldeck; S Gupta
Journal:  J Clin Immunol       Date:  1984-11       Impact factor: 8.317

7.  Augmentation of human K-cell activity with interferon.

Authors:  J R Ortaldo; S Pestka; R B Slease; M Rubinstein; R B Herberman
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

Review 8.  Do natural killer cells engage in regulated reactions against self to ensure homeostasis?

Authors:  G Cudkowicz; P S Hochman
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

9.  Human natural killer cell activity is augmented by interferon via recruitment of 'pre-NK' cells.

Authors:  E Saksela; T Timonen; K Cantell
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

10.  Purified human interleukin-2 enhances induction of immune interferon.

Authors:  K T Pearlstein; M A Palladino; K Welte; J Vilcek
Journal:  Cell Immunol       Date:  1983-08       Impact factor: 4.868

View more
  9 in total

Review 1.  Natural killer cells and autoimmunity.

Authors:  E Grunebaum; E Malatzky-Goshen; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 2.  Innate immunity and the pathogenesis of type 1 diabetes.

Authors:  Fabio Arturo Grieco; Francesco Vendrame; Isabella Spagnuolo; Francesco Dotta
Journal:  Semin Immunopathol       Date:  2010-04-10       Impact factor: 9.623

3.  Altered natural killer (NK) cell frequency and phenotype in latent autoimmune diabetes in adults (LADA) prior to insulin deficiency.

Authors:  C Akesson; K Uvebrant; C Oderup; K Lynch; R A Harris; A Lernmark; C-D Agardh; C M Cilio
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

4.  Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome.

Authors:  S Belanger; L-H Tai; S K Anderson; A P Makrigiannis
Journal:  Genes Immun       Date:  2008-06-05       Impact factor: 2.676

5.  An increased frequency of NK cell receptor and HLA-C group 1 combinations in early-onset type 1 diabetes.

Authors:  K L Mehers; A E Long; A R van der Slik; R J Aitken; V Nathwani; F S Wong; S Bain; G Gill; B O Roep; P J Bingley; K M Gillespie
Journal:  Diabetologia       Date:  2011-09-10       Impact factor: 10.122

6.  Natural killer cells from children with type 1 diabetes have defects in NKG2D-dependent function and signaling.

Authors:  Huilian Qin; I-Fang Lee; Constadina Panagiotopoulos; Xiaoxia Wang; Alvina D Chu; Paul J Utz; John J Priatel; Rusung Tan
Journal:  Diabetes       Date:  2011-01-26       Impact factor: 9.461

Review 7.  Natural Killer Cells in the Orchestration of Chronic Inflammatory Diseases.

Authors:  Luca Parisi; Barbara Bassani; Marco Tremolati; Elisabetta Gini; Giampietro Farronato; Antonino Bruno
Journal:  J Immunol Res       Date:  2017-03-27       Impact factor: 4.818

Review 8.  Type 1 Diabetes and Its Multi-Factorial Pathogenesis: The Putative Role of NK Cells.

Authors:  Valeria La Marca; Elena Gianchecchi; Alessandra Fierabracci
Journal:  Int J Mol Sci       Date:  2018-03-10       Impact factor: 5.923

Review 9.  The role of natural cytotoxicity receptors in various pathologies: emphasis on type I diabetes.

Authors:  Jonatan Enk; Ofer Mandelboim
Journal:  Front Immunol       Date:  2014-01-20       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.